News Category
Onco-Innovations has entered a non-binding LOI with Ifowonco Informatics to potentially acquire an exclusive option on a small-molecule LAG-3 inhibito...
Earth Science Tech's acquisition of Zoolzy LLC is set to enhance its pharmaceutical supply chain, potentially boosting profit margins, and enable expa...
SCHOTT Pharma's updated science-based climate targets, validated by the SBTi, shift focus to absolute Scope 3 emission reductions across the value cha...
Helus Pharma reports progress in its Phase 3 program for HLP003 in major depressive disorder, with topline data expected in Q4 2026, and provides fina...
VERAXA Biotech has moved its VXA-222 bispecific antibody-drug conjugate program into the next development stage and expanded its intellectual property...
Tonix Pharmaceuticals announced FDA feedback supporting its adaptive Phase 2 study of TNX-4800, a long-acting antibody for Lyme disease prevention, po...
VERAXA Biotech announced the advancement of its bispecific antibody-drug conjugate program VXA-222 after OmniAb completed discovery work, moving the c...
VERAXA Biotech appointed Christoph Erkel as CSO to lead development of its BiTAC platform for solid tumor cancer therapies, succeeding Rick Austin.
NanoViricides announced a registered direct offering expected to generate $3.8 million in gross proceeds, with warrants exercisable at $1.75 per share...
VERAXA Biotech AG appointed Christoph Erkel as CSO to advance its proprietary BiTAC platform for solid tumor cancer therapies, succeeding Rick Austin.
VERAXA Biotech AG announced it has received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting the development strategy for its lead B...
VERAXA Biotech announced it received Scientific Advice from Germany's Paul-Ehrlich-Institute for its BiTAC-TCE platform, clarifying development strate...
Siegfried has appointed Eduardo Montanha as Chief Operating Officer, effective September 1, 2026, to strengthen supply performance and operational eff...
NextPlat Corp has agreed to acquire an independent pharmacy near Pensacola, Florida, for $1.5 million, aiming to expand its PharmcoRx retail footprint...
Onco-Innovations Limited has finished its analytical reference standard program for the API supporting ONC010, strengthening CMC framework for clinica...
VERAXA Biotech has initiated cell line development for its lead BiTAC T-cell engager program in partnership with ATUM, a key step toward clinical tria...
The global sustained release polymers market is projected to reach USD 7.8 billion by 2036, growing at a 7.4% CAGR, as pharmaceutical companies increa...
VERAXA Biotech AG updates on its BiTAC platform progress and partnership strategy, prioritizing T-cell engager programs while monetizing non-core asse...
VERAXA Biotech has started cell line development for its lead BiTAC T-cell engager program through a collaboration with ATUM, advancing its promising ...
Pharmaceutical companies are increasingly committing substantial capital to preclinical antibody platforms, creating potential value for VERAXA Biotec...
Ace Therapeutics announces a full-spectrum preclinical pain research platform with diverse in vivo models and end-to-end services to accelerate analge...
Medios AG is closing its Aschaffenburg plant and consolidating production to improve profitability, affecting 32 employees, as regulatory price adjust...
Helus Pharma announced fiscal 2026 financial results and progress in its Phase 3 trial for major depressive disorder, with topline data expected in Q4...
Voyageur Pharmaceuticals has engaged Fluor Corporation to conduct feasibility studies for an iodine extraction facility in Oklahoma and an integrated ...
Knight Therapeutics repaid the full $60 million drawn from its credit facility to fund the Paladin acquisition, using operational cash flow, while mai...
Voyageur Pharmaceuticals is assessing potential locations in Oklahoma and Texas for a vertically integrated iodine and barium contrast media plant, ai...
Telomir Pharmaceuticals announced the publication of preclinical data in Biomedicine & Pharmacotherapy demonstrating that its lead candidate, Telomir-...
Helix BioPharma Corp. announced improved financial results for the nine months ended April 30, 2026, with a net loss of $2.374 million compared to $4....
Tonix Pharmaceuticals announced its participation in BTIG Infectious Disease Day 2026, highlighting its immunology pipeline including Lyme disease pro...
Helus Pharma announced that its Chief Medical Officer will participate in a fireside chat at the H.C. Wainwright 7th Annual Neuro Perspectives Hybrid ...
Onco-Innovations Limited has initiated process development and intermediate scale-up for ONC010's active ingredient, marking a key step toward IND-ena...
Voyageur Pharmaceuticals has submitted a multi-year exploration permit application for its Frances Creek barite project in British Columbia, aiming to...
Sharon Polsky releases a new book that cuts through hype and misinformation to provide clear, science-based guidance on GLP-1 weight loss medications,...
Carmed Pharmaceuticals announces a second peer-reviewed study in 2026 on its Vacrol® and S-Mix® formulations, published in Antioxidants, underscoring ...
Amerigo Scientific introduces a comprehensive range of research-grade and GMP-grade small molecules designed to support stem cell research, regenerati...
CNS Pharmaceuticals discusses its oversubscribed $22.5 million financing and strategic reset, indicating strong institutional investor confidence and ...
Tonix Pharmaceuticals announced a coverage agreement with a second major group purchasing organization, expanding TONMYA's commercial access to 52 mil...
Oncotelic Therapeutics will showcase its PDAOAI platform, built on Qdrant infrastructure, which accelerated two drug candidates from concept to IND fi...
Redwood AI Corp. is developing a proprietary AI platform for drug discovery, synthesis planning, and chemical analysis, targeting pharmaceutical, defe...
Voyageur Pharmaceuticals raised $5 million through a non-brokered private placement to fund FDA licensing and project development for its barium and i...
The Citizens Commission on Human Rights warns that organized psychiatry's pattern of downplaying antidepressant risks and opposing warnings could unde...
Stonegate Capital Partners updated coverage on Cingulate Inc. following an FDA Complete Response Letter focused on CMC issues, shifting the timeline b...
Quantum BioPharma is advancing a novel multiple sclerosis therapy through its subsidiary Lucid Psycheceuticals and expanding into the alcohol health m...
Revolution Medicines' new pill daraxonrasib targets KRAS mutations and has reportedly doubled survival in early trials, offering hope against a notori...
Onco-Innovations Limited announced successful kilogram-scale production of the B4 precursor for its lead PNKP inhibitor ONC010, advancing toward clini...
GeoVax Labs' CEO David Dodd comments on recent pharmaceutical acquisitions by Eli Lilly, interpreting them as a strategic shift toward viewing vaccine...
Quantum BioPharma's co-founder discusses the company's promising MS drug candidate Lucid-MS and commercial alcohol metabolism product unbuzzd™, highli...
Oncotelic Therapeutics is highlighted in a BioMedWire editorial for its Sapu003 program and Deciparticle platform, reflecting a broader biotech trend ...
